Fenofibrate Tablets, USP 145 mg, 90-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ, 08854, NDC 31722-596-90
Published October 3, 2018 · Recall initiated: September 12, 2018
Summary
FDA records drug Class III recall D-1211-2018, published October 3, 2018 and initiated September 12, 2018. Recalling firm: Hetero Labs, Ltd. - Unit III; Status: Terminated; Reported quantity: 5,424 bottles; Lot: Lot #: E181370, Exp. 5/2020. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Tablet/Capsule: A foreign identified as Valacyclovir tablet 500 mg was co-mingled in a bottle containing Fenofibrate Tablets, USP 145 mg.
What to do
Voluntary: Firm initiated · Letter
Get an email if FENOFIBRATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- FENOFIBRATE
- Manufacturer
- Hetero Labs, Ltd. - Unit III
- Distributor
- Indiana and Louisiana
- UPC
- 0331722596305
- Lot
- Lot #: E181370, Exp. 5/2020
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDAFenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India,July 1, 2026
- FDAFenofibrate Capsules 67 mg, USP, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited,April 16, 2025
- FDAFENOFIBRATE CAPSULES, UPS 67MG 100 CAPSULES NDC/UPC 27241-118-04; RX; CAPSULESJune 2, 2021
- FDAMinivelle (estradiol transdermal system) Patches, Delivers 0.075 mg/day, 8 count boxes, Rx only, Mfd. by:October 3, 2018
- FDAMontelukast Sodium Tablets, 10 mg*, 30-count bottles, Rx Only, By: Hetero, Hetero Labs Limited, Unit V,October 3, 2018
- FDAMinivelle (estradiol transdermal system) Patches, Delivers 0.025 mg/day, 8 count boxes, Rx only, Mfd. by:October 3, 2018
Questions about this recall
Was Fenofibrate Tablets, USP 145 mg, 90-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ, 08854, NDC 31722-596-90 recalled?
Yes. FDA published recall D-1211-2018 on October 3, 2018. Reported hazard: Presence of Foreign Tablet/Capsule: A foreign identified as Valacyclovir tablet 500 mg was co-mingled in a bottle containing Fenofibrate Tablets, USP 145 mg.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: FENOFIBRATE. UPC: 0331722596305.